Funded Projects › H2020

BIOSIM · Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

H2020Status: CLOSED1 October 2017 – 31 May 2019EU funding €2,029,325Call H2020-SMEInst-2016-2017

crisisRecovery

Consortium · 1 organisation

coordinator

VALITACELL LTD

IE · €2,029,325

Research fields

engineering and technology manufacturing engineering natural sciences software bioreactors social sciences productivity medical and health sciences vaccines

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.